EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Adenosine Deaminase-Mediated Purine Dysfunction Leads to DNA Repair Inhibition and Senescence in Sporadic Amyotrophic Lateral Sclerosis

Benjamin Hall, Yasmina M Ebrahim iD, Joanne L Sharpe iD, Sangeet Makhija, Brittany C S Ellis, Kari E Wong, Heather Walker iD, Miriam Yagüe-Capilla, Hannah O Timmons iD, Arian Bradley, Ella Nightingale, Rees Ross und 11 weitere

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27188236 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Benjamin Hall und 22 weiteren Autor:innen. Beteiligte Einrichtung: Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield S10 2HQ, UK. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Purines, Adenosine Deaminase, DNA Repair. Die Arbeit nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Sheffield, Foreign, Commonwealth & Development Office, NIHR Sheffield Biomedical Research Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterised by the death of motor neurons leading to paralysis and death generally 3–5 years post-symptom onset. ALS is a cell- and non-cell-autonomous disease, with glia such as astrocytes influencing disease pathology and progression. Our laboratory has previously identified purine metabolism dysfunction in induced neural progenitor cell-derived astrocytes (iAstrocytes) from sporadic ALS (SALS) cases, driven by loss of the enzyme adenosine deaminase (ADA). Here, we have demonstrated that loss of ADA, along with changes to ecto-5′-nucleotidase and hypoxanthine-guanine phosphoribosyl transferase led to disruption in purine metabolite levels, linked to the level of the ADA enzyme. These alterations were recapitulated in SALS CSF and post-mortem tissue, with ageing and sex affecting purine metabolite levels downstream of ADA and positively correlating with disease progression. Loss of ADA led to reduced 53BP1-mediated DNA repair and increased P16 levels, which was recapitulated in control iAstrocytes via ADA inhibition. Our findings indicate that TDP43 dysfunction drives impairment of ADA-mediated purine metabolism in vitro, leading to downstream effects that include DNA damage, likely through inhibition of DNA repair mechanisms, and the induction of cellular senescence. Furthermore, these results suggest that therapeutic targeting of the ADA pathway may help slow ALS disease progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisPurinesAdenosine DeaminaseDNA RepairCellular SenescenceHumansAstrocytesFemaleMaleDNA-Binding Proteins

Stichwörter der Autor:innen

ADAALSMNDastrocytemetabolomicspurine metabolism

Substanzen

PurinesAdenosine DeaminaseDNA-Binding Proteins

Autor:innen und Institutionen

  • Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield S10 2HQ, UK.
  • Metabolon Inc., Morrisville, NC 27560, USA.
  • biOMICS Mass Spectrometry Facility, University of Sheffield, Alfred Denny Building, Western Bank, Sheffield S10 2TN, UK.
  • SciLifeLab, Department of Oncology-Pathology, Karolinska Institute, 41012 Stockholm, Sweden.
  • Instituto de Biomedicina de Sevilla (IBiS), Avda Manuel Siurot S/N, 41013 Seville, Spain.
  • Departamento de Biologia Celular, Facultad de Biologia, Universidad de Sevilla, Avenida Reina Mercedes 6, 41012 Seville, Spain.

ORCID-Profile: Yasmina M Ebrahim, Joanne L Sharpe, Heather Walker, Hannah O Timmons, Nikita Soni, Guillaume M Hautbergue, Sean G Rudd, Ryan J H West, Pamela J Shaw, Scott P Allen

Förderung

  • University of Sheffield
  • Foreign, Commonwealth & Development Office
  • NIHR Sheffield Biomedical Research Centre
  • National Institute for Health and Care Research
  • MNDA 'A Multicentre Biomarker Resource Strategy' in ALS
  • Swedish Childhood Cancer Foundation
  • Swedish Cancer Society
  • Medical Research Council

Zitieren

APA

Hall, B., Ebrahim, Y. M., Sharpe, J. L., Makhija, S., Ellis, B. C. S., Wong, K. E., Walker, H., Yagüe-Capilla, M., Timmons, H. O., Bradley, A., Nightingale, E., Ross, R., Allen, C. F., Gatto, N., Garland, H., Soni, N., Kolb, S. J., Highley, J. R., Hautbergue, G. M., …, & Allen, S. P. (2026). Adenosine Deaminase-Mediated Purine Dysfunction Leads to DNA Repair Inhibition and Senescence in Sporadic Amyotrophic Lateral Sclerosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27188236

Vancouver

Hall B, Ebrahim YM, Sharpe JL, Makhija S, Ellis BCS, Wong KE, et al. Adenosine Deaminase-Mediated Purine Dysfunction Leads to DNA Repair Inhibition and Senescence in Sporadic Amyotrophic Lateral Sclerosis. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27188236

BibTeX
@article{Hall2026,
  author = {Hall, Benjamin and Ebrahim, Yasmina M and Sharpe, Joanne L and Makhija, Sangeet and Ellis, Brittany C S and Wong, Kari E and Walker, Heather and Yagüe-Capilla, Miriam and Timmons, Hannah O and Bradley, Arian and Nightingale, Ella and Ross, Rees and Allen, Chloe F and Gatto, Noemi and Garland, Herbie and Soni, Nikita and Kolb, Stephen J and Highley, J Robin and Hautbergue, Guillaume M and Rudd, Sean G and West, Ryan J H and Shaw, Pamela J and Allen, Scott P},
  title = {Adenosine Deaminase-Mediated Purine Dysfunction Leads to DNA Repair Inhibition and Senescence in Sporadic Amyotrophic Lateral Sclerosis},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27188236}
}
Kostenlos starten →